Lingohr & Partner Asset Management Gmb H Exelixis, Inc. Transaction History
Lingohr & Partner Asset Management Gmb H
- $55.2 Million
- Q2 2025
A detailed history of Lingohr & Partner Asset Management Gmb H transactions in Exelixis, Inc. stock. As of the latest transaction made, Lingohr & Partner Asset Management Gmb H holds 20,901 shares of EXEL stock, worth $921,107. This represents 1.67% of its overall portfolio holdings.
Number of Shares
20,901
Previous 114,461
81.74%
Holding current value
$921,107
Previous $4.23 Million
78.21%
% of portfolio
1.67%
Previous 1.06%
Shares
6 transactions
Others Institutions Holding EXEL
# of Institutions
624Shares Held
257MCall Options Held
1.57MPut Options Held
730K-
Black Rock Inc. New York, NY33.5MShares$1.48 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.26 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA22.5MShares$993 Million4.78% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8MShares$653 Million0.88% of portfolio
-
State Street Corp Boston, MA11.8MShares$520 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $14.2B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...